China’s drug market is opening up

11 November 2019 - Beijing’s health-care reforms are giving global pharmaceutical companies better access to the world’s second-largest drug market. ...

Read more →

Mapping of health technology assessment in China: situation analysis and international comparison

28 October 2019 - Chen and colleagues have analysed the current development of HTA in China and to identify areas ...

Read more →

In generic drug plants in China and India, data falsification is still a problem

29 October 2019 - As the generic drug industry faces allegations of data manipulation, headlines about carcinogen-tainted blood pressure medicine, ...

Read more →

Dialogue with Chinese authorities on medicine regulation

25 October 2019 - The Deputy Commissioner of the Chinese National Medical Product Administration, Dr Chen Shifei, visited EMA on ...

Read more →

China wants big pharma to bend the knee in new health care system

21 October 2019 - Less than five years ago, Chinese health care was a closed-off, low-quality system where the richest ...

Read more →

Merck’s Keytruda (pembrolizumab) now approved as monotherapy in China for first-line treatment of certain patients with advanced non-small cell lung cancer (NSCLC) whose tumours express PD-L1

2 October 2019 - Keytruda is first anti-PD-1 therapy approved as monotherapy and in combination with chemotherapy in first-line setting for ...

Read more →

Erbitux in combination with FOLFOX or FOLFIRI approved as first-line therapy for patients in China with RAS wild type metastatic colorectal cancer

27 September 2019 - Pivotal Phase III evidence shows significant improvements with Erbitux in combination with FOLFOX versus FOLFOX alone ...

Read more →

How China’s new drug buying program is causing pain

24 September 2019 - China is changing the way it procures drugs.  ...

Read more →

China’s drug price cuts pressure Lipitor and other foreign pills

24 September 2019 - Government is changing the way it procures generic drugs. ...

Read more →

U.S. officials worried about Chinese control of American drug supply

13 September 2019 - "Basically we've outsourced our entire industry to China," retired Brig. Gen. John Adams told NBC News. "That ...

Read more →

China’s grip on pharmaceutical drugs is a national security issue

10 September 2019 - If you take a pill every day to treat high blood pressure or high cholesterol, you ...

Read more →

Tagrisso approved in China as a first-line treatment for EGFR-mutated non-small cell lung cancer

4 September 2019 - In the Phase III FLAURA trial, Tagrisso significantly increased the time patients lived without disease progression ...

Read more →

China expands drug bulk-buy program, puts pressure on pharma firms

2 September 2019 - China has expanded a pilot drug bulk-buying program to almost the entire country in an attempt ...

Read more →

China eases rules on cheap drug imports to fight chronic diseases

27 August 2019 - China said it would reduce the penalties for the sale and import of unapproved drugs, effectively ...

Read more →

China loosens curbs on small, unapproved drug imports

26 August 2019 - China said on Monday it was relaxing drug laws to give greater leniency to people who ...

Read more →